Search Results 101-110 of 16783 for Selective estrogen receptor modulator

1. A Study Evaluating Safety and Efficacy of the Addition of ABT-888 Plus Carboplatin Versus the Addition of Carboplatin to Standard Chemotherapy Versus Standard Chemotherapy in Subjects with Early Stage Triple Negative Breast Cancer - Mayo Clinic

   ... selective estrogen receptor modulator (SERM). Subjects must have discontinued use of such agents prior to beginning study treatment. A history of seizure ...

2. A Study to Evaluate Cellular Senescence with Senolytics to Improve Skeletal Health in Older Humans - Mayo Clinic

   estrogen (E) therapy or treatment with a selective E receptor modulator, except for vaginal estrogen cream use, or teriparatide, abaloparatide, romosozumab ...

3. Clinical trials - Oncology (Medical)

   ... estrogen receptor positive/human epidermal growth factor receptor 2 negative (ER+/HER2-) advanced or metastatic breast cancer that has progressed on ...

4. Z-endoxifen shows promise as new treatment for common breast cancer type - Mayo Clinic News Network

   The final results of a first-in-human phase I study of Z-endoxifen in women with estrogen receptor · positive metastatic breast cancer showed that the ...

5. Mayo Clinic News Network Title: Potential new breast cancer drug is 'very exciting' / Date

   estrogen receptor-positive breast cancer who had failed standard therapies. One- third of them saw significant benefits with few, if any, side effects ...

6. Clinical trials - Oncology (Medical)

   ... receptor positive, estrogen receptor-positive, human epidermal growth receptor-2 negative metastatic breast cancer after progression on previous endocrine ...

7. Study to Evaluate the Effects of Vitamin B3 Derivative on Bone, Skeletal, Muscle and Metabolic Functions in Aging - Mayo Clinic

   Treatment within the past 3 years with estrogen. Treatment within the past 3 years with selective estrogen receptor modulator. Participating Mayo Clinic ...

8. De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA) - Mayo Clinic

   Current therapy with any endocrine therapy such as raloxifene (Evista®), tamoxifen, or other selective estrogen receptor modulators (SERMs), either for ...

9. Breast Clinic - Clinical trials

   ... receptor positive, estrogen receptor-positive, human epidermal growth receptor-2 negative metastatic breast cancer after progression on previous endocrine ...

10. Characterization of Circulating Tumor Cells (CTC) From Patients With Metastatic Breast Cancer Using the CTC-Endocrine Therapy Index - Mayo Clinic

    ... (estrogen receptor [ER] and Bcl-2) and resistance (HER2 and Ki67) has been demonstrated. An algorithm for a CTC-Endocrine Therapy Index (CTC-ETI) has been ...